The Director Of Teladoc Health Inc. (TDOC) Purchased 1,642 Shares

As of Thursday close, Teladoc Health Inc.’s (NYSE:TDOC) stock was up $2.01, moving up 7.01 percent to $30.69. The average number of shares traded per day over the past five days has been 12,585,140 shares. 1 time new highs have been achieved over the past 5 days, with a -$4.91 fall in that time frame. In the last twenty days, the average volume was 14,460,896, while in the previous 50 days, it was 8,066,190.


Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .

Sponsored


Since last month, TDOC stock retreated -54.04%. Shares of the company fell to $27.38 on 05/12/22, the lowest level in the past month. A 52-week high of $174.32 was reached on 01/04/22 after having rallying from a 52-week low of $27.80. Since the beginning of this year, TDOC’s stock price has dropped by -66.58% or -$61.13, and marked a new high 2 times. However, the stock has declined by -82.39% since its 52-week high.

Teladoc Health Inc. (TDOC) last reported insider trading activity 67 days ago on Mar 07. Trencher Daniel, the SVP Corporate Strategy of the company, disposed of 1,642 shares for $66.74 on Mar 07. It resulted in a $109,582 divestment by the insider. Vandervoort Adam C sold 3,879 shares at an average price of $66.74 on Mar 07. The insider now owns 11,983 shares following the transaction. On Mar 07, Chief Marketing Officer Verstraete Stephany sold 3,774 shares at $66.74 apiece. The transaction was valued at $251,865.

Valuation Metrics

The stock’s beta is 0.81. Besides these, the trailing price-to-sales (P/S) ratio of 2.46, the price-to-book (PB) ratio of 0.54, and the price-to-cash flow ratio of 30.97 may also be considered.

Financial Health

In the three months ended September 29, Teladoc Health Inc.’s quick ratio stood at 3.70, while its current ratio was 3.90, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending September 29 was 0.17, and the total debt-to-equity ratio was 0.17. On the profitability front, the trailing twelve-month gross margin is 67.80% percent. Based on annual data, TDOC earned $1.38 billion in gross profit and brought in $2.03 billion in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -2.00%. Return on equity (ROE) for the past 12 months was -48.30%.

According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. TDOC’s revenue rose 48.91% to -$827.72 million during the quarter, while net income inched up to $565.35 million. While analysts expected Teladoc Health Inc. to report -$0.65 quarterly earnings, the actual figure was -$0.53 per share, beating the consensus estimate by 18.50%. During the quarter, the company generated -$5.68 million in EBITDA. The liabilities of Teladoc Health Inc. were 1.95 billion at the end of its most recent quarter ended September 29, and its total debt was $1.29 billion. The value of shareholders’ equity is $161.18 million.

Technical Picture

This quick technical analysis looks at Teladoc Health Inc.’s (TDOC) price momentum. With a historical volatility rate of 104.69%, the RSI 9-day stood at 26.07% on 12 May.

With respect to its five-day moving average, the current Teladoc Health Inc. price is down by -13.79% percent or -$4.91. At present, TDOC shares trade -55.39% below its 20-day simple moving average and -68.61% percent below its 100-day simple moving average. However, the stock is currently trading approximately -57.66% below its SMA50 and -79.78% below its SMA200.

Stochastic coefficient K was 5.94% and Stochastic coefficient D was 5.94%, while ATR was 4.76. Given the Stochastic reading of 9.88% for the 14-day period, the RSI (14) reading has been calculated as 27.93%. As of today, the MACD Oscillator reading stands at -4.02, while the 14-day reading stands at -9.23.

Analyst Ratings

Teladoc Health Inc. downgraded its rating on Teladoc Health Inc. (NYSE: TDOC) to a Hold in a note to investors on May 05, 2022. The analysts firm previously had a Buy rating on the stock.Teladoc Health Inc. (TDOC) has been rated Overweight by analysts. According to 0 brokerage firms, TDOC is a sell, and 21 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Teladoc Health Inc. stock as buy, with 8 recommending it as overweight.

With a median target price of $43.50, the current consensus forecast for the stock is $30.00 – $141.00. Based on these forecasts, analysts predict Teladoc Health Inc. (TDOC) will achieve an average price target of $51.25.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Hot Topics

Related Articles